19391000087103: GamaSTAN S/D 15 to 18 percent solution for injection Grifols Therapeutics Inc. (real clinical drug)

SNOMED CT Concept\produit pharmaceutique ou biologique\Medicinal product (product)\...

\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing polypeptide (product)\Product containing protein (product)\Product containing plasma protein (product)\produits d'immunoglobuline\Ig immune globulin unspecified\...

\Product containing only human immunoglobulin (medicinal product)\Product containing only normal human immunoglobulin (medicinal product)\Product containing only normal human immunoglobulin in parenteral dose form (medicinal product form)\GamaSTAN S/D 15 to 18 percent solution for injection Grifols Therapeutics Inc. (real clinical drug)

\Product containing normal human immunoglobulin (medicinal product)\Product containing only normal human immunoglobulin (medicinal product)\Product containing only normal human immunoglobulin in parenteral dose form (medicinal product form)\GamaSTAN S/D 15 to 18 percent solution for injection Grifols Therapeutics Inc. (real clinical drug)
\Product containing normal human immunoglobulin (medicinal product)\Product containing normal human immunoglobulin in parenteral dose form (medicinal product form)\Product containing only normal human immunoglobulin in parenteral dose form (medicinal product form)\GamaSTAN S/D 15 to 18 percent solution for injection Grifols Therapeutics Inc. (real clinical drug)

\Product manufactured as parenteral dose form (product)\Product containing normal human immunoglobulin in parenteral dose form (medicinal product form)\Product containing only normal human immunoglobulin in parenteral dose form (medicinal product form)\GamaSTAN S/D 15 to 18 percent solution for injection Grifols Therapeutics Inc. (real clinical drug)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 26-May 2015. Module: Canada Health Infoway English module (core metadata concept)

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
GamaSTAN S/D 15 to 18 percent solution for injection Grifols Therapeutics Inc. (real clinical drug)	est un(e) (attribut)	Ig immune globulin unspecified	false	Inferred relationship	Some
GamaSTAN S/D 15 to 18 percent solution for injection Grifols Therapeutics Inc. (real clinical drug)	a pour principe actif (attribut)	immunoglobuline humaine	false	Inferred relationship	Some	1
GamaSTAN S/D 15 to 18 percent solution for injection Grifols Therapeutics Inc. (real clinical drug)	Has supplier	Grifols Therapeutics Inc. (supplier)	true	Inferred relationship	Some
GamaSTAN S/D 15 to 18 percent solution for injection Grifols Therapeutics Inc. (real clinical drug)	est un(e) (attribut)	Product containing only normal human immunoglobulin in parenteral dose form (medicinal product form)	true	Inferred relationship	Some
GamaSTAN S/D 15 to 18 percent solution for injection Grifols Therapeutics Inc. (real clinical drug)	Count of base of active ingredient	un	false	Inferred relationship	Some
GamaSTAN S/D 15 to 18 percent solution for injection Grifols Therapeutics Inc. (real clinical drug)	a pour principe actif (attribut)	immunoglobuline humaine normale (substance)	true	Inferred relationship	Some	1
GamaSTAN S/D 15 to 18 percent solution for injection Grifols Therapeutics Inc. (real clinical drug)	a une forme pharmaceutique (attribut)	forme pharmaceutique pour usage parentéral (forme pharmaceutique)	true	Inferred relationship	Some

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

Reference Sets

Administered tradename codes for passive immunizing agents reference set (foundation metadata concept)

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
138881000087117	GamaSTAN 15 to 18 percent solution for injection Grifols Therapeutics Inc. (real clinical drug)	en	Fully specified name	Inactive	Entire term case sensitive (core metadata concept)	Canada Health Infoway English module (core metadata concept)
151661000087117	GamaSTAN S/D 15 to 18 percent solution for injection Grifols Therapeutics Inc. (real clinical drug)	en	Fully specified name	Active	Entire term case sensitive (core metadata concept)	Canada Health Infoway English module (core metadata concept)
151671000087114	GamaSTAN S/D 15 to 18 percent solution for injection Grifols Therapeutics Inc.	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	Canada Health Infoway English module (core metadata concept)
151681000087111	Ig GamaSTAN S/D Grif	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	Canada Health Infoway English module (core metadata concept)
62431000087118	Ig GamaSTAN Grif	en	Synonym (core metadata concept)	Inactive	Entire term case sensitive (core metadata concept)	Canada Health Infoway English module (core metadata concept)
62441000087112	GamaSTAN 15 to 18 percent solution for injection Grifols Therapeutics Inc. (product)	en	Fully specified name	Inactive	Entire term case sensitive (core metadata concept)	Canada Health Infoway English module (core metadata concept)
62451000087110	GamaSTAN 15 to 18 percent solution for injection Grifols Therapeutics Inc.	en	Synonym (core metadata concept)	Inactive	Entire term case sensitive (core metadata concept)	Canada Health Infoway English module (core metadata concept)
74101000087119	Ig GamaSTAN Grif	fr	Synonym (core metadata concept)	Inactive	Entire term case sensitive (core metadata concept)	Canada Health Infoway French module (core metadata concept)
79211000087114	GamaSTAN 15 to 18 percent solution for injection Grifols Therapeutics Inc. (product)	fr	Fully specified name	Inactive	Entire term case sensitive (core metadata concept)	Canada Health Infoway French module (core metadata concept)